n-3 Fatty Acids in the Treatment of Diabetic Patients
Open Access
- 1 April 2007
- journal article
- review article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (4) , 1012-1026
- https://doi.org/10.2337/dc06-1332
Abstract
No abstract availableThis publication has 158 references indexed in Scilit:
- The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibitionProceedings of the National Academy of Sciences, 2006
- Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)American Heart Journal, 2003
- Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedsideAmerican Heart Journal, 2003
- Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic DyslipidemiaExperimental and Clinical Endocrinology & Diabetes, 2003
- Effect of Eicosapentaenoic Acid on Glucose-Induced Diacylglycerol Synthesis in Cultured Bovine Aortic Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemiaAtherosclerosis, 1993
- Partial Normalization by Dietary Cod-Liver Oil of Increased Microvascular Albumin Leakage in Patients with Insulin-Dependent Diabetes and AlbuminuriaNew England Journal of Medicine, 1989
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxaneJournal of Molecular Medicine, 1986
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985